Stephen Andrew Welch insider trades

Open-market stock purchases and sales by Stephen Andrew Welch, EVP & Head of Spec Generics at Mallinckrodt plc, from SEC Form 4 filings since Dec 14, 2022.

Recent trades

DateStockTradeValue
Nov 10, 2025 Keenova Therapeutics plcSold (not open market)—

Companies traded

  • NONE Mallinckrodt plc: other filings, last Jan 1, 2025
  • MNKTQ Mallinckrodt plc: other filings, last Nov 14, 2023
  • MNK Mallinckrodt plc: 1 buy, last Aug 17, 2023

Get free alerts when Stephen Andrew Welch files a new trade →